Showing results (31-40 of 379) with videos related to

Sort By:
Pageof 38
The Journal of Dermatology|July 20, 2011
Psychosomatic or allergic symptoms? High levels for somatization in patients with drug intoleranceJessica C Hassel, Daniel Danner, Alexander J Hassel
Biomolecules|March 29, 2023
S100 as Serum Tumor Marker in Advanced Uveal MelanomaMartin Salzmann, Alexander H Enk, Jessica C Hassel
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|May 25, 2022
Adverse effects under immune checkpoint inhibitors on [18F]FDG PET/CT imagingChristos Sachpekidis, Jessica C Hassel, Antonia Dimitrakopoulou-Strauss
European Journal of Cancer (Oxford, England : 1990)|February 20, 2017
Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunityRalf Gutzmer, Anika Koop, Friedegund Meier, et al.
Melanoma Research|November 18, 2008
STAT5 contributes to antiapoptosis in melanomaJessica C Hassel, Dirk Winnemöller, Manfred Schartl, et al.
Cancers|April 13, 2024
Early Serum Markers for Immune Checkpoint Inhibitor Induced Hypophysitis in Melanoma PatientsFouad Mitri, Devayani Machiraju, Christina Naoum, et al.
Cancer Treatment Reviews|February 29, 2016
Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapyThomas K Eigentler, Jessica C Hassel, Carola Berking, et al.
Cancer Medicine|June 23, 2017
Anti-PD-1 antibodies in metastatic uveal melanoma: a treatment option?Carolin Bender, Alexander Enk, Ralf Gutzmer, et al.
Cancer Treatment Reviews|May 28, 2017
Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactionsJessica C Hassel, Lucie Heinzerling, Jens Aberle, et al.
Internal Medicine (Tokyo, Japan)|January 8, 2013
Necrolytic migratory erythema in a patient with neuroendocrine carcinomaMichaela Gronau, Dirk Jäger, Alexander H Enk, et al.
Pageof 38